bêta
IA Trial Radar
L'essai clinique NCT06109844 pour Ulcère veineux de la jambe, Cicatrisation des plaies, Plaie non cicatrisante, Cytokines est en recrutement. Consultez la vue en carte du Radar des Essais Cliniques et les outils de découverte par IA pour tous les détails, ou posez vos questions ici.
Un essai clinique correspond aux filtres sélectionnés
Vue en carte

FORCEREPAIR - A Wound Exudate Investigation

En recrutement
Les détails de l'essai clinique sont principalement disponibles en anglais. Cependant, l'IA Trial Radar peut vous aider ! Cliquez simplement sur 'Expliquer l'essai' pour voir et discuter des informations sur l'essai dans la langue sélectionnée.
L'étude clinique NCT06109844 est un essai observationnel pour Ulcère veineux de la jambe, Cicatrisation des plaies, Plaie non cicatrisante, Cytokines. Son statut actuel est : en recrutement. L'étude a débuté le 24 janvier 2024 et vise à recruter 20 participants. Dirigé par Bispebjerg Hospital, l'essai devrait être terminé d'ici le 30 juin 2025. Les données du site ClinicalTrials.gov ont été mises à jour pour la dernière fois le 9 juillet 2024.
Résumé succinct
The observational longitudinal study will collect wound exudate from twenty patients with venous leg ulcers. Wound exudate samples are collected using twenty-four-hour collection with polyurethane foam, bandages and the NovaSwab method. Each patient is seen four times where wound exudate and the bacteria microbiome are sampled and wound size is monitored with advanced planimetric tools.
Description détaillée
This dual centre longitudinal observational study will run from January 2024 to January 2025. The investigation will include twenty patients over four weeks including four study visits. Sampling of wound exudate can take place on every visit and will be made with the polyurethane discs, the NovaSwab technique and waste bandages. The wound bacteria microbiome is sampled with routine bacterial swabs. Tape strips will be used to assess perilesional skin and control sites of normal skin and will primarily measure skin inflammation parameters. Clinical pictures are taken and analysed using advanced planimetric tools. Patients enrolled receive standard wound care; allowing all kinds of dressing. However when consenting to twenty-four-hour-collection patients will not be allowed to wear active bandages or receive antibiotic treatment for that period. Compression, wound dressings, and use of topical and oral antibiotics will be registered. For the storage of samples, a research biobank is used, and leftover material will be stored in a biobank for future research.
Titre officiel

FORCEREPAIR - A Wound Exudate Investigation

Conditions
Ulcère veineux de la jambeCicatrisation des plaiesPlaie non cicatrisanteCytokines
Publications
Articles scientifiques et travaux de recherche publiés sur cet essai clinique:
Autres identifiants de l'essai
  • FORCEREPAIR-01
  • 104834 (Identifiant de registre) (Research Ethics Comittee)
Numéro NCT
Date de début (réel)
2024-01-24
Dernière mise à jour publiée
2024-07-09
Date de fin (estimée)
2025-06-30
Inscription (estimée)
20
Type d'essai
Observationnel
Statut
En recrutement
Mots clés
Venous Leg Ulcer
Varicose Ulcer
Cytokines
Wound Exudate
Wound Healing
Wound Inflammation
Wound Microbiome
Bras / Interventions
Groupe de participants/BrasIntervention/Traitement
N/A
Standard de soins
Patients enrolled in this observational study receive standard of care. Treatment, ointments, compression and bandages will be registered at every visit.
Critère principal d'évaluation
Critères d'évaluationDescription de critèresPériode
Wound Exudate Effects on Proliferation of Healthy Primary Human Fibroblasts
Proliferation
Four weeks
Wound Exudate Effects on Matrix Formation by Healthy Primary Human Fibroblasts
Matrix Formation
Four weeks
Wound Exudate Effects on Release of Pro-inflammatory Mediators
Release of pro-inflammatory Mediators
Four weeks
Wound Exudate Effects on Cellular Gene Expression Profiles In Healthy Primary Human Fibroblasts
Gene Expression Profiles
Four weeks
Exploratory Wound Exudate Compound and Device Testing
Wound Exudate Compounds
Four weeks
Critère secondaire d'évaluation
Critères d'évaluationDescription de critèresPériode
Wound Exudate Profile Relation to Percentage Area Reduction
Four Weeks
Wound Exudate Profile Relation to Wound Microbiome Profile
Four Weeks
Percentage Area Reduction Relation to Wound Microbiome Profile
Four Weeks
Comparisson of Wound Exudate Sampling Techniques
Polyurethane disc twenty-four-hour sampling, Bandages and NovaSwabs
Four Weeks
Wound Microbiome 16 rRNA/18sRNA
Bioburden, Diversity and Pathogens
Four Weeks
Wound Perilesional Skin Inflammation
Tape Strips from perilesional skin and control site.
Four Weeks
Critères d'éligibilité

Âges éligibles
Adulte, Adulte âgé
Âge minimum
18 Years
Sexes éligibles
Tous
  • Adults fulfilling all inclusion criteria
  • Age >18 years
  • Venous leg ulcer diagnosis and classic characteristics (localisation, varicose veins, brown-orange hyperpigmentation, leg oedema, stasis dermatitis, atrophie blanche or lipodermatosclerosis) verified by a wound expert (if in doubt venous doppler will be used for verification)
  • Wound Area equal to or above 1 cm2 (measured with a ruler length x width)
  • Patient can understand Danish
  • Patient can comply with protocol
  • Patient is fully informed about the study and has given informed consent

  • Venous leg ulcer with communication to bone
  • Known or suspected cancer in the wound
  • Allergies towards products used in the study, e.g. polyurethane foam and tegaderm
  • Dementia
  • Judgement by the investigator that the patient is not suited for study participation
Bispebjerg Hospital logoBispebjerg Hospital
  • Akribes Biomedical GmbH logoAkribes Biomedical GmbH
  • Vascular Research Unit and Department of Vascular Surgery logoVascular Research Unit and Department of Vascular Surgery
Partie responsable de l'essai
Frederik Plum, Investigateur principal, MD, Ph.D Fellow at University of Copenhagen, Bispebjerg Hospital
Contact central de l'essai
Contact: Frederik Plum, MD, +4529671247, [email protected]
Contact: Klaus Kirketerp-Møller, MD, Ph.D, +4540199087, [email protected]
2 Centres de l'essai dans 1 pays

Northwest

Danish Wound Healing Center, Bispebjerg Hospital, Copenhagen, Northwest, 2400, Denmark
Frederik Plum, MD, Contact, +4529671247, [email protected]
Klaus Kirketerp-Møller, Consultant, Contact, +4540199087, [email protected]
Frederik Plum, MD, Investigateur principal
En recrutement
Vascular Research Unit and Department of Vascular Surgery, Viborg Regional Hospital, Viborg, 8800, Denmark
Annette Høgh, MD, Contact, [email protected]
En recrutement